Exelixis (EXEL) Interest Coverage Ratio Growth (1y) (2011 - 2017)
Exelixis (EXEL) Interest Coverage Ratio Growth (1y) (2011 - 2017) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
-303.06% |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
18.06% |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
67.94% |
| 10 |
Exelixis |
13.37 Bn |
12.59 Bn |
590.86 Mn |
- |
| Date | Value |
|---|
| Jun 30, 2017 |
364.69% |
| Mar 31, 2017 |
195.64% |
| Sep 30, 2016 |
126.01% |
| Jun 30, 2016 |
8.05% |
| Mar 31, 2016 |
-160.21% |
| Sep 30, 2015 |
15.10% |
| Jun 30, 2015 |
48.78% |
| Mar 31, 2015 |
66.79% |
| Dec 31, 2014 |
25.09% |
| Sep 30, 2014 |
14.16% |
| Jun 30, 2014 |
-11.88% |
| Mar 31, 2014 |
-79.63% |
| Dec 31, 2013 |
-152.63% |
| Sep 30, 2013 |
-47.64% |
| Jun 30, 2013 |
42.93% |
| Mar 31, 2013 |
44.76% |
| Dec 31, 2012 |
-136.25% |
| Sep 30, 2012 |
-117.22% |
| Jun 30, 2012 |
-84.91% |
| Mar 31, 2012 |
7.47% |
